nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprostadil—Warmth—Liotrix—hypothyroidism	0.0218	0.0555	CcSEcCtD
Alprostadil—SLCO2A1—Transport of organic anions—AVP—hypothyroidism	0.0212	0.0779	CbGpPWpGaD
Alprostadil—SLCO3A1—Transport of organic anions—AVP—hypothyroidism	0.0201	0.0738	CbGpPWpGaD
Alprostadil—PTGER2—adrenal cortex—hypothyroidism	0.0157	0.0469	CbGeAlD
Alprostadil—Cardiac failure congestive—Liothyronine—hypothyroidism	0.0154	0.0391	CcSEcCtD
Alprostadil—SLCO2B1—Transport of organic anions—AVP—hypothyroidism	0.0117	0.0428	CbGpPWpGaD
Alprostadil—PTGER2—adrenal gland—hypothyroidism	0.0113	0.0338	CbGeAlD
Alprostadil—PTGER2—blood—hypothyroidism	0.0113	0.0338	CbGeAlD
Alprostadil—Acute coronary syndrome—Liothyronine—hypothyroidism	0.0106	0.0269	CcSEcCtD
Alprostadil—PTGER2—female gonad—hypothyroidism	0.0106	0.0316	CbGeAlD
Alprostadil—Myocardial infarction—Liothyronine—hypothyroidism	0.0105	0.0268	CcSEcCtD
Alprostadil—PTGER1—female gonad—hypothyroidism	0.01	0.0299	CbGeAlD
Alprostadil—PTGER2—Prostaglandin Synthesis and Regulation—PRL—hypothyroidism	0.00964	0.0354	CbGpPWpGaD
Alprostadil—PTGER2—testis—hypothyroidism	0.00937	0.028	CbGeAlD
Alprostadil—Wheezing—Levothyroxine—hypothyroidism	0.00915	0.0233	CcSEcCtD
Alprostadil—Wheezing—Dextrothyroxine—hypothyroidism	0.00915	0.0233	CcSEcCtD
Alprostadil—PTGIR—heart—hypothyroidism	0.00889	0.0266	CbGeAlD
Alprostadil—Feeling hot—Liotrix—hypothyroidism	0.00883	0.0225	CcSEcCtD
Alprostadil—PTGIR—cardiovascular system—hypothyroidism	0.00839	0.0251	CbGeAlD
Alprostadil—SLCO2A1—adrenal cortex—hypothyroidism	0.00804	0.024	CbGeAlD
Alprostadil—SLCO2A1—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	0.00787	0.0289	CbGpPWpGaD
Alprostadil—SLCO3A1—heart—hypothyroidism	0.00785	0.0234	CbGeAlD
Alprostadil—SLCO2A1—heart—hypothyroidism	0.00777	0.0232	CbGeAlD
Alprostadil—PTGIR—gonad—hypothyroidism	0.00761	0.0227	CbGeAlD
Alprostadil—Cardiac failure congestive—Dextrothyroxine—hypothyroidism	0.00754	0.0192	CcSEcCtD
Alprostadil—Cardiac failure congestive—Levothyroxine—hypothyroidism	0.00754	0.0192	CcSEcCtD
Alprostadil—SLCO3A1—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	0.00746	0.0274	CbGpPWpGaD
Alprostadil—Hypertension—Liothyronine—hypothyroidism	0.00724	0.0184	CcSEcCtD
Alprostadil—ABCC5—heart—hypothyroidism	0.00711	0.0212	CbGeAlD
Alprostadil—Hypoglycaemia—Levothyroxine—hypothyroidism	0.00701	0.0178	CcSEcCtD
Alprostadil—Hypoglycaemia—Dextrothyroxine—hypothyroidism	0.00701	0.0178	CcSEcCtD
Alprostadil—Wheezing—Liotrix—hypothyroidism	0.00673	0.0171	CcSEcCtD
Alprostadil—SLCO3A1—gonad—hypothyroidism	0.00672	0.0201	CbGeAlD
Alprostadil—Tachycardia—Liothyronine—hypothyroidism	0.00668	0.017	CcSEcCtD
Alprostadil—PTGIR—adrenal gland—hypothyroidism	0.00664	0.0198	CbGeAlD
Alprostadil—PTGIR—blood—hypothyroidism	0.00663	0.0198	CbGeAlD
Alprostadil—SLCO3A1—pituitary gland—hypothyroidism	0.00656	0.0196	CbGeAlD
Alprostadil—PTGER1—Prostaglandin Synthesis and Regulation—PRL—hypothyroidism	0.00651	0.0239	CbGpPWpGaD
Alprostadil—PTGIR—Prostaglandin Synthesis and Regulation—PRL—hypothyroidism	0.00651	0.0239	CbGpPWpGaD
Alprostadil—Cardiac arrest—Dextrothyroxine—hypothyroidism	0.00651	0.0166	CcSEcCtD
Alprostadil—Cardiac arrest—Levothyroxine—hypothyroidism	0.00651	0.0166	CcSEcCtD
Alprostadil—SLCO2A1—pituitary gland—hypothyroidism	0.00649	0.0194	CbGeAlD
Alprostadil—PTGIR—thyroid gland—hypothyroidism	0.0064	0.0191	CbGeAlD
Alprostadil—Hypotension—Liothyronine—hypothyroidism	0.0064	0.0163	CcSEcCtD
Alprostadil—PTGIR—female gonad—hypothyroidism	0.00619	0.0185	CbGeAlD
Alprostadil—Sepsis—Liotrix—hypothyroidism	0.00602	0.0153	CcSEcCtD
Alprostadil—ABCC5—pituitary gland—hypothyroidism	0.00594	0.0177	CbGeAlD
Alprostadil—SLCO3A1—adrenal gland—hypothyroidism	0.00586	0.0175	CbGeAlD
Alprostadil—SLCO3A1—blood—hypothyroidism	0.00586	0.0175	CbGeAlD
Alprostadil—SLCO2A1—adrenal gland—hypothyroidism	0.0058	0.0173	CbGeAlD
Alprostadil—Sweating increased—Dextrothyroxine—hypothyroidism	0.00576	0.0147	CcSEcCtD
Alprostadil—Sweating increased—Levothyroxine—hypothyroidism	0.00576	0.0147	CcSEcCtD
Alprostadil—Swelling—Liotrix—hypothyroidism	0.0057	0.0145	CcSEcCtD
Alprostadil—SLCO3A1—thyroid gland—hypothyroidism	0.00565	0.0169	CbGeAlD
Alprostadil—SLCO2A1—thyroid gland—hypothyroidism	0.0056	0.0167	CbGeAlD
Alprostadil—SLCO2B1—heart—hypothyroidism	0.00556	0.0166	CbGeAlD
Alprostadil—Cardiac failure congestive—Liotrix—hypothyroidism	0.00555	0.0141	CcSEcCtD
Alprostadil—PTGIR—testis—hypothyroidism	0.00549	0.0164	CbGeAlD
Alprostadil—SLCO3A1—female gonad—hypothyroidism	0.00546	0.0163	CbGeAlD
Alprostadil—Body temperature increased—Liothyronine—hypothyroidism	0.00541	0.0138	CcSEcCtD
Alprostadil—SLCO2A1—female gonad—hypothyroidism	0.00541	0.0162	CbGeAlD
Alprostadil—SLCO2A1—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.00537	0.0197	CbGpPWpGaD
Alprostadil—ABCC5—adrenal gland—hypothyroidism	0.00531	0.0158	CbGeAlD
Alprostadil—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.0052	0.0132	CcSEcCtD
Alprostadil—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.0052	0.0132	CcSEcCtD
Alprostadil—PTGIR—liver—hypothyroidism	0.00519	0.0155	CbGeAlD
Alprostadil—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.00517	0.0132	CcSEcCtD
Alprostadil—Myocardial infarction—Levothyroxine—hypothyroidism	0.00517	0.0132	CcSEcCtD
Alprostadil—Hypoglycaemia—Liotrix—hypothyroidism	0.00516	0.0131	CcSEcCtD
Alprostadil—ABCC5—thyroid gland—hypothyroidism	0.00512	0.0153	CbGeAlD
Alprostadil—SLCO3A1—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.00509	0.0187	CbGpPWpGaD
Alprostadil—PTGIR—cerebellum—hypothyroidism	0.00507	0.0151	CbGeAlD
Alprostadil—ABCC5—female gonad—hypothyroidism	0.00495	0.0148	CbGeAlD
Alprostadil—ABCC4—heart—hypothyroidism	0.00493	0.0147	CbGeAlD
Alprostadil—SLCO3A1—testis—hypothyroidism	0.00484	0.0145	CbGeAlD
Alprostadil—SLCO2A1—testis—hypothyroidism	0.0048	0.0143	CbGeAlD
Alprostadil—Cardiac arrest—Liotrix—hypothyroidism	0.00478	0.0122	CcSEcCtD
Alprostadil—Blood creatinine increased—Liotrix—hypothyroidism	0.00471	0.012	CcSEcCtD
Alprostadil—PTGER2—G alpha (s) signalling events—TSHB—hypothyroidism	0.00469	0.0172	CbGpPWpGaD
Alprostadil—PTGER2—G alpha (s) signalling events—TSHR—hypothyroidism	0.00469	0.0172	CbGpPWpGaD
Alprostadil—Hypokalaemia—Liotrix—hypothyroidism	0.00458	0.0117	CcSEcCtD
Alprostadil—SLCO3A1—liver—hypothyroidism	0.00458	0.0137	CbGeAlD
Alprostadil—SLCO2A1—liver—hypothyroidism	0.00453	0.0135	CbGeAlD
Alprostadil—ABCC5—NRF2 pathway—SLC5A7—hypothyroidism	0.00447	0.0164	CbGpPWpGaD
Alprostadil—SLCO3A1—cerebellum—hypothyroidism	0.00447	0.0134	CbGeAlD
Alprostadil—SLCO2A1—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.00445	0.0163	CbGpPWpGaD
Alprostadil—Flushing—Dextrothyroxine—hypothyroidism	0.00439	0.0112	CcSEcCtD
Alprostadil—Flushing—Levothyroxine—hypothyroidism	0.00439	0.0112	CcSEcCtD
Alprostadil—ABCC5—testis—hypothyroidism	0.00439	0.0131	CbGeAlD
Alprostadil—SLCO2B1—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	0.00432	0.0159	CbGpPWpGaD
Alprostadil—Sweating increased—Liotrix—hypothyroidism	0.00424	0.0108	CcSEcCtD
Alprostadil—SLCO3A1—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.00422	0.0155	CbGpPWpGaD
Alprostadil—Bronchitis—Liotrix—hypothyroidism	0.00418	0.0106	CcSEcCtD
Alprostadil—SLCO2B1—adrenal gland—hypothyroidism	0.00415	0.0124	CbGeAlD
Alprostadil—ABCC5—liver—hypothyroidism	0.00415	0.0124	CbGeAlD
Alprostadil—ABCC5—cerebellum—hypothyroidism	0.00405	0.0121	CbGeAlD
Alprostadil—SLCO2B1—thyroid gland—hypothyroidism	0.00401	0.012	CbGeAlD
Alprostadil—Nervousness—Levothyroxine—hypothyroidism	0.004	0.0102	CcSEcCtD
Alprostadil—Nervousness—Dextrothyroxine—hypothyroidism	0.004	0.0102	CcSEcCtD
Alprostadil—SLCO2B1—female gonad—hypothyroidism	0.00387	0.0116	CbGeAlD
Alprostadil—Acute coronary syndrome—Liotrix—hypothyroidism	0.00382	0.00973	CcSEcCtD
Alprostadil—Renal failure—Liotrix—hypothyroidism	0.00381	0.0097	CcSEcCtD
Alprostadil—Myocardial infarction—Liotrix—hypothyroidism	0.0038	0.00968	CcSEcCtD
Alprostadil—ABCC4—adrenal gland—hypothyroidism	0.00368	0.011	CbGeAlD
Alprostadil—ABCC4—blood—hypothyroidism	0.00368	0.011	CbGeAlD
Alprostadil—Convulsion—Levothyroxine—hypothyroidism	0.00357	0.00909	CcSEcCtD
Alprostadil—Convulsion—Dextrothyroxine—hypothyroidism	0.00357	0.00909	CcSEcCtD
Alprostadil—ABCC4—thyroid gland—hypothyroidism	0.00355	0.0106	CbGeAlD
Alprostadil—Hypoaesthesia—Liotrix—hypothyroidism	0.00346	0.00882	CcSEcCtD
Alprostadil—SLCO2B1—testis—hypothyroidism	0.00343	0.0103	CbGeAlD
Alprostadil—ABCC4—female gonad—hypothyroidism	0.00343	0.0102	CbGeAlD
Alprostadil—Shock—Levothyroxine—hypothyroidism	0.00331	0.00842	CcSEcCtD
Alprostadil—Shock—Dextrothyroxine—hypothyroidism	0.00331	0.00842	CcSEcCtD
Alprostadil—Tachycardia—Dextrothyroxine—hypothyroidism	0.00328	0.00835	CcSEcCtD
Alprostadil—Tachycardia—Levothyroxine—hypothyroidism	0.00328	0.00835	CcSEcCtD
Alprostadil—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00325	0.00827	CcSEcCtD
Alprostadil—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00325	0.00827	CcSEcCtD
Alprostadil—SLCO2B1—liver—hypothyroidism	0.00325	0.0097	CbGeAlD
Alprostadil—Flushing—Liotrix—hypothyroidism	0.00323	0.00822	CcSEcCtD
Alprostadil—SLCO2B1—cerebellum—hypothyroidism	0.00317	0.00947	CbGeAlD
Alprostadil—PTGIR—G alpha (s) signalling events—TSHB—hypothyroidism	0.00317	0.0116	CbGpPWpGaD
Alprostadil—PTGIR—G alpha (s) signalling events—TSHR—hypothyroidism	0.00317	0.0116	CbGpPWpGaD
Alprostadil—ABCC4—NRF2 pathway—SLC5A7—hypothyroidism	0.0031	0.0114	CbGpPWpGaD
Alprostadil—ABCC4—testis—hypothyroidism	0.00304	0.00908	CbGeAlD
Alprostadil—SLCO2B1—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.00295	0.0108	CbGpPWpGaD
Alprostadil—Nervousness—Liotrix—hypothyroidism	0.00294	0.00749	CcSEcCtD
Alprostadil—ABCC4—liver—hypothyroidism	0.00287	0.00859	CbGeAlD
Alprostadil—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00277	0.00705	CcSEcCtD
Alprostadil—Feeling abnormal—Levothyroxine—hypothyroidism	0.00277	0.00705	CcSEcCtD
Alprostadil—PTGER2—G alpha (s) signalling events—AVP—hypothyroidism	0.00276	0.0101	CbGpPWpGaD
Alprostadil—SLCO2A1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00273	0.01	CbGpPWpGaD
Alprostadil—Syncope—Liotrix—hypothyroidism	0.00272	0.00692	CcSEcCtD
Alprostadil—Loss of consciousness—Liotrix—hypothyroidism	0.00266	0.00678	CcSEcCtD
Alprostadil—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00266	0.00677	CcSEcCtD
Alprostadil—Abdominal pain—Levothyroxine—hypothyroidism	0.00266	0.00677	CcSEcCtD
Alprostadil—Body temperature increased—Levothyroxine—hypothyroidism	0.00266	0.00677	CcSEcCtD
Alprostadil—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00266	0.00677	CcSEcCtD
Alprostadil—Convulsion—Liotrix—hypothyroidism	0.00263	0.00668	CcSEcCtD
Alprostadil—Hypertension—Liotrix—hypothyroidism	0.00262	0.00666	CcSEcCtD
Alprostadil—SLCO3A1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00259	0.00949	CbGpPWpGaD
Alprostadil—PTGER1—G alpha (q) signalling events—TRH—hypothyroidism	0.00256	0.00939	CbGpPWpGaD
Alprostadil—PTGER2—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00251	0.0092	CbGpPWpGaD
Alprostadil—Oedema—Liotrix—hypothyroidism	0.00247	0.0063	CcSEcCtD
Alprostadil—Infection—Liotrix—hypothyroidism	0.00246	0.00625	CcSEcCtD
Alprostadil—SLCO2B1—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.00244	0.00897	CbGpPWpGaD
Alprostadil—Shock—Liotrix—hypothyroidism	0.00243	0.00619	CcSEcCtD
Alprostadil—Tachycardia—Liotrix—hypothyroidism	0.00241	0.00614	CcSEcCtD
Alprostadil—Asthenia—Levothyroxine—hypothyroidism	0.00241	0.00614	CcSEcCtD
Alprostadil—Asthenia—Dextrothyroxine—hypothyroidism	0.00241	0.00614	CcSEcCtD
Alprostadil—Hyperhidrosis—Liotrix—hypothyroidism	0.00239	0.00609	CcSEcCtD
Alprostadil—Pruritus—Levothyroxine—hypothyroidism	0.00238	0.00605	CcSEcCtD
Alprostadil—Pruritus—Dextrothyroxine—hypothyroidism	0.00238	0.00605	CcSEcCtD
Alprostadil—Hypotension—Liotrix—hypothyroidism	0.00231	0.00588	CcSEcCtD
Alprostadil—Diarrhoea—Levothyroxine—hypothyroidism	0.0023	0.00586	CcSEcCtD
Alprostadil—Diarrhoea—Dextrothyroxine—hypothyroidism	0.0023	0.00586	CcSEcCtD
Alprostadil—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.00229	0.0084	CbGpPWpGaD
Alprostadil—SLCO2A1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.00226	0.0083	CbGpPWpGaD
Alprostadil—PTGER2—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00223	0.0082	CbGpPWpGaD
Alprostadil—PTGER2—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00223	0.0082	CbGpPWpGaD
Alprostadil—SLCO2A1—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.00215	0.00788	CbGpPWpGaD
Alprostadil—SLCO3A1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.00214	0.00787	CbGpPWpGaD
Alprostadil—Rash—Levothyroxine—hypothyroidism	0.00212	0.0054	CcSEcCtD
Alprostadil—Rash—Dextrothyroxine—hypothyroidism	0.00212	0.0054	CcSEcCtD
Alprostadil—Dermatitis—Levothyroxine—hypothyroidism	0.00212	0.00539	CcSEcCtD
Alprostadil—Dermatitis—Dextrothyroxine—hypothyroidism	0.00212	0.00539	CcSEcCtD
Alprostadil—Headache—Levothyroxine—hypothyroidism	0.00211	0.00536	CcSEcCtD
Alprostadil—Headache—Dextrothyroxine—hypothyroidism	0.00211	0.00536	CcSEcCtD
Alprostadil—Feeling abnormal—Liotrix—hypothyroidism	0.00204	0.00519	CcSEcCtD
Alprostadil—SLCO3A1—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.00203	0.00747	CbGpPWpGaD
Alprostadil—Nausea—Dextrothyroxine—hypothyroidism	0.002	0.00508	CcSEcCtD
Alprostadil—Nausea—Levothyroxine—hypothyroidism	0.002	0.00508	CcSEcCtD
Alprostadil—Body temperature increased—Liotrix—hypothyroidism	0.00196	0.00498	CcSEcCtD
Alprostadil—Abdominal pain—Liotrix—hypothyroidism	0.00196	0.00498	CcSEcCtD
Alprostadil—PTGER2—GPCR ligand binding—TRH—hypothyroidism	0.00191	0.00701	CbGpPWpGaD
Alprostadil—PTGIR—G alpha (s) signalling events—AVP—hypothyroidism	0.00187	0.00685	CbGpPWpGaD
Alprostadil—PTGER2—G alpha (s) signalling events—POMC—hypothyroidism	0.00184	0.00674	CbGpPWpGaD
Alprostadil—ABCC5—NRF2 pathway—SLC5A5—hypothyroidism	0.00179	0.00656	CbGpPWpGaD
Alprostadil—Asthenia—Liotrix—hypothyroidism	0.00177	0.00452	CcSEcCtD
Alprostadil—Pruritus—Liotrix—hypothyroidism	0.00175	0.00445	CcSEcCtD
Alprostadil—PTGER2—GPCR ligand binding—TSHB—hypothyroidism	0.0017	0.00625	CbGpPWpGaD
Alprostadil—PTGER2—GPCR ligand binding—TSHR—hypothyroidism	0.0017	0.00625	CbGpPWpGaD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00169	0.00622	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00169	0.00622	CbGpPWpGaD
Alprostadil—Diarrhoea—Liotrix—hypothyroidism	0.00169	0.00431	CcSEcCtD
Alprostadil—SLCO2A1—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.00169	0.0062	CbGpPWpGaD
Alprostadil—Dizziness—Liotrix—hypothyroidism	0.00164	0.00416	CcSEcCtD
Alprostadil—SLCO3A1—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.0016	0.00588	CbGpPWpGaD
Alprostadil—Rash—Liotrix—hypothyroidism	0.00156	0.00397	CcSEcCtD
Alprostadil—Dermatitis—Liotrix—hypothyroidism	0.00156	0.00397	CcSEcCtD
Alprostadil—Headache—Liotrix—hypothyroidism	0.00155	0.00394	CcSEcCtD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00151	0.00554	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00151	0.00554	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00151	0.00554	CbGpPWpGaD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00151	0.00554	CbGpPWpGaD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.0015	0.0055	CbGpPWpGaD
Alprostadil—Nausea—Liotrix—hypothyroidism	0.00147	0.00374	CcSEcCtD
Alprostadil—ABCC5—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00143	0.00526	CbGpPWpGaD
Alprostadil—PTGER1—G alpha (q) signalling events—AVP—hypothyroidism	0.00134	0.00493	CbGpPWpGaD
Alprostadil—PTGER2—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.00132	0.00483	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—TRH—hypothyroidism	0.00129	0.00473	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—TRH—hypothyroidism	0.00129	0.00473	CbGpPWpGaD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.00124	0.00456	CbGpPWpGaD
Alprostadil—PTGIR—G alpha (s) signalling events—POMC—hypothyroidism	0.00124	0.00455	CbGpPWpGaD
Alprostadil—ABCC4—NRF2 pathway—SLC5A5—hypothyroidism	0.00124	0.00455	CbGpPWpGaD
Alprostadil—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.0012	0.00441	CbGpPWpGaD
Alprostadil—ABCC5—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.00119	0.00436	CbGpPWpGaD
Alprostadil—SLCO2B1—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.00118	0.00433	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—TSHB—hypothyroidism	0.00115	0.00422	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—TSHR—hypothyroidism	0.00115	0.00422	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—TSHB—hypothyroidism	0.00115	0.00422	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—TSHR—hypothyroidism	0.00115	0.00422	CbGpPWpGaD
Alprostadil—SLCO2A1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.00109	0.004	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—TRH—hypothyroidism	0.00108	0.00396	CbGpPWpGaD
Alprostadil—SLCO3A1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.00103	0.00379	CbGpPWpGaD
Alprostadil—ABCC4—Platelet degranulation—IGF1—hypothyroidism	0.00101	0.00371	CbGpPWpGaD
Alprostadil—PTGER2—GPCR ligand binding—AVP—hypothyroidism	0.001	0.00368	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000993	0.00365	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—TRH—hypothyroidism	0.00098	0.0036	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—IYD—hypothyroidism	0.000968	0.00355	CbGpPWpGaD
Alprostadil—ABCC4—Response to elevated platelet cytosolic Ca2+—IGF1—hypothyroidism	0.000962	0.00353	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—TSHR—hypothyroidism	0.000961	0.00353	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—TSHB—hypothyroidism	0.000961	0.00353	CbGpPWpGaD
Alprostadil—SLCO2B1—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000928	0.00341	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—SH2B3—hypothyroidism	0.000916	0.00336	CbGpPWpGaD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000889	0.00327	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000889	0.00327	CbGpPWpGaD
Alprostadil—PTGER2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000875	0.00321	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—TSHB—hypothyroidism	0.000873	0.00321	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—TSHR—hypothyroidism	0.000873	0.00321	CbGpPWpGaD
Alprostadil—SLCO2A1—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000858	0.00315	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—ATP5O—hypothyroidism	0.000823	0.00302	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000823	0.00302	CbGpPWpGaD
Alprostadil—SLCO3A1—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000814	0.00299	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—TPO—hypothyroidism	0.000774	0.00284	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—TRH—hypothyroidism	0.000729	0.00268	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—TRH—hypothyroidism	0.000729	0.00268	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	0.000727	0.00267	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—AVP—hypothyroidism	0.000677	0.00249	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—AVP—hypothyroidism	0.000677	0.00249	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CLTC—hypothyroidism	0.00067	0.00246	CbGpPWpGaD
Alprostadil—PTGER2—GPCR ligand binding—POMC—hypothyroidism	0.000666	0.00245	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—TRH—hypothyroidism	0.000662	0.00243	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—TRH—hypothyroidism	0.000662	0.00243	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—TSHB—hypothyroidism	0.000649	0.00238	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—TSHB—hypothyroidism	0.000649	0.00238	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—TSHR—hypothyroidism	0.000649	0.00238	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—TSHR—hypothyroidism	0.000649	0.00238	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—VAV3—hypothyroidism	0.000629	0.00231	CbGpPWpGaD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000599	0.0022	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000591	0.00217	CbGpPWpGaD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000591	0.00217	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—TSHB—hypothyroidism	0.00059	0.00217	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—TSHB—hypothyroidism	0.00059	0.00217	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—TSHR—hypothyroidism	0.00059	0.00217	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—TSHR—hypothyroidism	0.00059	0.00217	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—VAV3—hypothyroidism	0.000588	0.00216	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—TRH—hypothyroidism	0.000579	0.00212	CbGpPWpGaD
Alprostadil—ABCC5—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000573	0.0021	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—AVP—hypothyroidism	0.000567	0.00208	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—SH2B3—hypothyroidism	0.000546	0.002	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—VAV3—hypothyroidism	0.000534	0.00196	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—TSHB—hypothyroidism	0.000516	0.00189	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—TSHR—hypothyroidism	0.000516	0.00189	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—AVP—hypothyroidism	0.000515	0.00189	CbGpPWpGaD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000472	0.00173	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—SH2B3—hypothyroidism	0.00046	0.00169	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CLTC—hypothyroidism	0.000452	0.00166	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CLTC—hypothyroidism	0.000452	0.00166	CbGpPWpGaD
Alprostadil—ABCC5—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000451	0.00166	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—POMC—hypothyroidism	0.00045	0.00165	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—POMC—hypothyroidism	0.00045	0.00165	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	0.000448	0.00164	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—VAV3—hypothyroidism	0.000397	0.00146	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—VAV3—hypothyroidism	0.000397	0.00146	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000397	0.00146	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—TRH—hypothyroidism	0.000391	0.00144	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—TRH—hypothyroidism	0.000391	0.00144	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—IGF1—hypothyroidism	0.000387	0.00142	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—AVP—hypothyroidism	0.000383	0.00141	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—AVP—hypothyroidism	0.000383	0.00141	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—POMC—hypothyroidism	0.000377	0.00138	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—VAV3—hypothyroidism	0.000375	0.00138	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—VAV3—hypothyroidism	0.000361	0.00132	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—VAV3—hypothyroidism	0.000361	0.00132	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—TSHB—hypothyroidism	0.000358	0.00132	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—TSHB—hypothyroidism	0.000348	0.00128	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—TSHB—hypothyroidism	0.000348	0.00128	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—TSHR—hypothyroidism	0.000348	0.00128	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—TSHR—hypothyroidism	0.000348	0.00128	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—AVP—hypothyroidism	0.000348	0.00128	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—AVP—hypothyroidism	0.000348	0.00128	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—POMC—hypothyroidism	0.000342	0.00126	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—PRL—hypothyroidism	0.000341	0.00125	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PIK3C2A—hypothyroidism	0.000319	0.00117	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—VAV3—hypothyroidism	0.000316	0.00116	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000313	0.00115	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—SH2B3—hypothyroidism	0.000311	0.00114	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—SH2B3—hypothyroidism	0.000311	0.00114	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—AVP—hypothyroidism	0.000304	0.00112	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PRL—hypothyroidism	0.000283	0.00104	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—SLC5A5—hypothyroidism	0.000268	0.000985	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—POMC—hypothyroidism	0.000254	0.000934	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—POMC—hypothyroidism	0.000254	0.000934	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—POMC—hypothyroidism	0.000231	0.000848	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—POMC—hypothyroidism	0.000231	0.000848	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—IGF1—hypothyroidism	0.000231	0.000847	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PRL—hypothyroidism	0.00023	0.000846	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PRL—hypothyroidism	0.00023	0.000846	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—VAV3—hypothyroidism	0.000213	0.000782	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—VAV3—hypothyroidism	0.000213	0.000782	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—AVP—hypothyroidism	0.000205	0.000754	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—AVP—hypothyroidism	0.000205	0.000754	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—POMC—hypothyroidism	0.000202	0.000742	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IGF1—hypothyroidism	0.000194	0.000713	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—POMC—hypothyroidism	0.00014	0.000515	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—POMC—hypothyroidism	0.000136	0.000501	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—POMC—hypothyroidism	0.000136	0.000501	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IGF1—hypothyroidism	0.000131	0.000482	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IGF1—hypothyroidism	0.000131	0.000482	CbGpPWpGaD
